Selective inhibition of plasma kallikrein protects brain from reperfusion injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 849-854

  Storini, Claudio ^a   Bergamaschini, Luigi ^b   Gesuete, Raffaella ^a   Rossi, Emanuela ^b   Maiocchi, Diana ^b   De Simoni, Maria Grazia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA KALLIKREIN; PROTEIN DX 88; PROTEIN INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG INHIBITION; DRUG SELECTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SCORING SYSTEM; STAINING; SWELLING; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN EDEMA; CELL COUNT; CEREBROVASCULAR DISORDERS; FLUORESCENT DYES; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURONS; ORGANIC CHEMICALS; PLASMA KALLIKREIN; REPERFUSION INJURY;

EID: 33745948312     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105064     Document Type: Article

References (32)

1. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, et al. (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-131.
2. Boels K and Schaller HC (2003) Identification and characterisation of GPR100 as a novel human G-protein-coupled bradykinin receptor. Br J Pharmacol 140:932-938.
3. Chao J and Chao L (2005) Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 90:291-298.
4. Clark WM, Lessov NK, Dixon MP, and Eckenstein F (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19:641-648.
5. De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, and Bergamaschini L (2004) The powerful neuroprotective action of C1-inhibitor on brain ischemiareperfusion injury does not require C1q. Am J Pathol 164:1857-1863.
6. De Simoni MG, Storini C, Barba M, Catapano L, Arabia AM, Rossi E, and Bergamaschini L (2003) Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Met 23:232-239.
7. 2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. Br J Pharmacol 139:1539-1547.
8. 2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:978-989.
9. Hallenbeck JM and Dutka AJ (1990) Background review and current concepts of reperfusion injury. Arch Neurol 47:1245-1254.
10. Kaur J, Zhao Z, Klein GM, Lo EH, and Buchan AM (2004) The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24:945-963.
11. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, and Warach S (2004) Early bloodbrain barrier disruption in human focal brain ischemia. Ann Neurol 56:468-477.
12. Lehmberg J, Beck J, Baethmann A, and Uhl E (2003) Bradykinin antagonists reduce leukocyte-endothelium interactions after global cerebral ischemia. J Cereb Blood Flow Metab 23:441-448.
13. 2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Brain Res 1069:227-234.
14. McIntosh JC, Mervin-Blake S, Conner E, and Wright JR (1996) Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages. Am J Physiol 271:L310-319.
15. 2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology. Br J Pharmacol 143:938-941.
16. Raidoo DM and Bhoola KD (1998) Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue. Pharmacol Ther 79:105-127.
17. 2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke 28:1430-1436.
18. Schmued LC, Albertson C, and Sikker W (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Research 751:37-46.
19. Shariat-Madar Z, Mahdi F, and Schmaier AH (2002) Assembly and activation of the plasma kallikrein/kinin system: a new interpretation. Int Immunopharmacol 2:1841-1849.
20. 1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J Immunol 172:2542-2548.
21. Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C, Bergamaschini L, and De Simoni MG (2005) C1 inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Disease 19:10-17.
22. Swanson R, Morton M, Tsao-Wu G, Savalos R, Davidson C, and Sharp F (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293.
23. Veeravalli KK and Akula A (2004) Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction. Pharmacol Res 49:23-29.
24. Wagner S, Kalb P, Lukosava M, Hilgenfeldt U, and Schwaninger M (2002) Activation of the tissue kallikrein-kinin system in stroke. J Neurol Sci 202:75-76.
25. Walport MJ (2001a) Complement: first of two parts. N Engl J Med 344:1058-1066.
26. Walport MJ (2001b) Complement: second of two parts. N Engl J Med 344:1140-1144.
27. Williams A and Baird LG (2003) DX-88 and HAE: a developmental perspective. Transfus Apher Sci 29:255-258.
28. Xia CF, Yin H, Borlongan CV, Chao L, and Chao J (2004) Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43:452-459.
29. Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, and Chao J (2006) Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther 17:206-219.
30. Yang GY, Mao Y, Zhou LF, Ye W, Liu XH, Gong C, and Lorris Betz A (1999) Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist. Brain Res Mol Brain Res 72:129-137.
31. Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, and Baethmann A (2002) Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Res 950:268-278.
32. Zuraw BL (2005) Current and future therapy for hereditary angioedema. Clin Immunol 114:10-16.